NCT01390519View on ClinicalTrials.gov

A Norwegian Observational Trial Evaluating the Treatment of Advanced Renal Cell Cancer Patients Under Treatment of Afinitor

CompletedOBSERVATIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2011

Primary Completion Date

December 31, 2015

Study Completion Date

December 31, 2015

Conditions
Metastatic Renal Cell Carcinoma (mRCC)
Interventions
OTHER

everolimis

Trial Locations (3)

4615

Novartis Investigative Site, Kristiansand

7006

Novartis Investigative Site, Trondheim

9038

Novartis Investigative Site, Tromsø

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY